Table 3.

The information of patients in traditional Sedlis criteria groups and new risk groups

Groups according to Sedlis criteria	Total (n = 481)	Recurrence (n = 35, 7.3%)	Death (n = 20, 4.2%)
Sedlis criteria (detailed)
None	337 (70.1)	22 (62.9)	13 (65.0)
LVSI + Deep 1/3	32 (6.7)	3 (8.6)	1 (5.0)
LVSI + Middle 1/3 + Tumor size ≥2 cm	39 (8.1)	3 (8.6)	2 (10.0)
LVSI + Superficial 1/3 + Tumor size ≥5 cm	0 (0.0)	0 (0.0)	0 (0.0)
Middle or deep 1/3 + Tumor size ≥4 cm	73 (15.2)	7 (20.0)	4 (20.0)
Sedlis criteria
No	337 (70.1)	22 (62.9)	13 (65.0)
Yes	144 (29.9)	13 (37.1)	7 (35.0)
Risk group of recurrence
Low‐risk group	224 (46.6)	7 (20.0)	4 (20.0)
High‐risk group	257 (53.4)	28 (80.0)	16 (80.0)
Risk group of death
Low‐risk group	248 (51.6)	10 (28.6)	4 (20.0)
High‐risk group	233 (48.4)	25 (71.4)	16 (80.0)

Values are presented as n (%).

Abbreviation: LVSI, lymphovascular space invasion.